会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL GENE STS 15
    • 新基因STS 15
    • WO2006084722A2
    • 2006-08-17
    • PCT/EP2006/001217
    • 2006-02-10
    • DSM IP ASSETS B.V.CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12N9/14C12P17/04
    • C12P7/60C12N9/14C12P17/04
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成(以下也称为维生素C)的蛋白质的新鉴定的基因。 本发明还涉及包含新基因及其片段的全长多核苷酸序列的多核苷酸,由多核苷酸及其片段编码的新多肽及其功能等同物。 本发明还涉及所述多核苷酸和多肽作为生物技术工具在从微生物生产维生素C中的用途,其中所述多核苷酸和/或编码多肽的修饰对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/方法。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 2. 发明申请
    • ALCOHOL DEHYDROGENASE GENE FROM GLUCONOBACTER OXYDANS
    • 来自葡萄糖酸氧化酶的酒精脱氢酶基因
    • WO2006084721A1
    • 2006-08-17
    • PCT/EP2006/001216
    • 2006-02-10
    • DSM IP ASSETS B.V.CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12N9/04C12P17/04
    • C12P17/04C12N9/0006
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成(以下也称为维生素C)的蛋白质的新鉴定的基因。 本发明还涉及包含新基因及其片段的全长多核苷酸序列的多核苷酸,由多核苷酸及其片段编码的新多肽及其功能等同物。 本发明还涉及所述多核苷酸和多肽作为生物技术工具在从微生物生产维生素C中的用途,其中所述多核苷酸和/或编码多肽的修饰对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/方法。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 3. 发明申请
    • GENE RCS O1
    • WO2006084729A1
    • 2006-08-17
    • PCT/EP2006/001224
    • 2006-02-10
    • DSM IP ASSETS B.V.CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12N9/02C12P17/04
    • C12N9/0055C12N9/0006C12N9/0057C12P17/04
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成(以下也称为维生素C)的蛋白质的新鉴定的基因。 本发明还涉及包含新基因及其片段的全长多核苷酸序列的多核苷酸,由多核苷酸及其片段编码的新多肽及其功能等同物。 本发明还涉及所述多核苷酸和多肽在从微生物生产维生素C中作为生物技术工具的用途,其中所述多核苷酸和/或编码多肽的修饰对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/方法。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 4. 发明申请
    • GENE STS 17
    • 基因STS 17
    • WO2006084723A1
    • 2006-08-17
    • PCT/EP2006/001218
    • 2006-02-10
    • DSM IP ASSETS B.V.CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12N9/00C12P17/04
    • C12P17/04C07K14/195C12P7/60
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成(以下也称为维生素C)的蛋白质的新鉴定的基因。 本发明还涉及包含新基因及其片段的全长多核苷酸序列的多核苷酸,由多核苷酸及其片段编码的新多肽及其功能等同物。 本发明还涉及所述多核苷酸和多肽在从微生物生产维生素C中作为生物技术工具的用途,其中所述多核苷酸和/或编码多肽的修饰对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/方法。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 5. 发明申请
    • NOVEL GENE STS 07
    • 新基因ST 07
    • WO2006084706A2
    • 2006-08-17
    • PCT/EP2006/001198
    • 2006-02-10
    • DSM IP ASSETS B.V.CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12P17/04C07K14/195
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成(以下也称为维生素C)的蛋白质的新鉴定的基因。 本发明还涉及包含新基因及其片段的全长多核苷酸序列的多核苷酸,由多核苷酸及其片段编码的新多肽及其功能等同物。 本发明还涉及所述多核苷酸和多肽在从微生物生产维生素C中作为生物技术工具的用途,其中所述多核苷酸和/或编码多肽的修饰对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/方法。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 8. 发明公开
    • GENE RCS 25
    • 基因RCS 25
    • EP1846551A1
    • 2007-10-24
    • EP06706854.4
    • 2006-02-10
    • DSM IP Assets B.V.
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12N9/00C12P17/04
    • C12P17/04C07K14/195
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成的蛋白质(以下也称为维生素C)的新鉴定的基因。 本发明的特征还在于包含新基因及其片段的全长多核苷酸序列的多核苷酸,由该多核苷酸及其片段编码的新多肽以及它们的功能等价物。 本发明还涉及所述多核苷酸和多肽作为生物技术工具在由微生物生产维生素C中的用途,由此修饰所述多核苷酸和/或编码的多肽对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/过程。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。
    • 9. 发明公开
    • GENE RCS 21
    • 基因RCS 21
    • EP1846565A1
    • 2007-10-24
    • EP06706853.6
    • 2006-02-10
    • DSM IP Assets B.V.
    • CHEVREUX, BastienMAYER, Anne FrançoiseMEURY, AnjaMOUNCEY, Nigel JohnSHINJOH, Masako
    • C12P17/04C12P7/60
    • C12P17/04C07K14/195
    • The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of said polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of said polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in said microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms. The invention also relates to genetically engineered microorganisms and their use for the direct production of Vitamin C.
    • 本发明涉及编码参与L-抗坏血酸合成的蛋白质(以下也称为维生素C)的新鉴定的基因。 本发明的特征还在于包含新基因及其片段的全长多核苷酸序列的多核苷酸,由该多核苷酸及其片段编码的新多肽以及它们的功能等价物。 本发明还涉及所述多核苷酸和多肽作为生物技术工具在由微生物生产维生素C中的用途,由此修饰所述多核苷酸和/或编码的多肽对产量,产量和/或 所述微生物中发酵产物的生产效率。 还包括使用多核苷酸和修饰的多核苷酸序列转化宿主微生物的方法/过程。 本发明还涉及基因工程微生物及其用于直接生产维生素C的用途。